The Modern Polyurethane-Coated Implant in Breast Augmentation: Long-Term Clinical Experience.
BACKGROUND
First-generation polyurethane foam-coated breast implants were associated with a low risk of capsular contracture (CC), but the risk of CC with modern polyurethane-coated silicone implants has not been established.


OBJECTIVE
The authors sought to determine the long-term rates of CC after primary breast augmentation with Microthane, a polyurethane-coated silicone gel implant.


METHODS
A total of 131 patients (255 breasts) were evaluated in a retrospective study. Data were compiled from postoperative follow-up sessions at 2 weeks; 1, 3, 6, and 12 months; and annually thereafter. Rates of various complications, including CC, were determined.


RESULTS
CC developed in 3 of the 255 implanted breasts (1.2%; Baker grade III or IV), and postoperative hematoma occurred in 2 implanted breasts (0.8%). Spontaneous CC that was not associated with other complications was observed in 1 implanted breast (0.4%). All instances of CC occurred before the 31st postoperative month.


CONCLUSIONS
For patients who undergo primary breast augmentation with modern polyurethane-coated implants, the long-term risk of CC is low.


METHODS
3 Therapeutic.
Dr Pompei is Unit Head and Dr Arelli is a Plastic Surgeon, San Camillo Plastic and Reconstructive Surgery Unit, Rome, Italy. Dr Evangelidou is a Plastic Surgeon, Emirates Hospital Group Plastic and Reconstructive Surgery Department, Dubai, United Arab Emirates. Dr Ferrante is a Researcher, National Center of Disease Prevention and Health Promotion, Italian National Institute of Health, Rome, Italy.
Stefano
S
Pompei
Dr Pompei is Unit Head and Dr Arelli is a Plastic Surgeon, San Camillo Plastic and Reconstructive Surgery Unit, Rome, Italy. Dr Evangelidou is a Plastic Surgeon, Emirates Hospital Group Plastic and Reconstructive Surgery Department, Dubai, United Arab Emirates. Dr Ferrante is a Researcher, National Center of Disease Prevention and Health Promotion, Italian National Institute of Health, Rome, Italy.
Dora
D
Evangelidou
Dr Pompei is Unit Head and Dr Arelli is a Plastic Surgeon, San Camillo Plastic and Reconstructive Surgery Unit, Rome, Italy. Dr Evangelidou is a Plastic Surgeon, Emirates Hospital Group Plastic and Reconstructive Surgery Department, Dubai, United Arab Emirates. Dr Ferrante is a Researcher, National Center of Disease Prevention and Health Promotion, Italian National Institute of Health, Rome, Italy.
Floriana
F
Arelli
Dr Pompei is Unit Head and Dr Arelli is a Plastic Surgeon, San Camillo Plastic and Reconstructive Surgery Unit, Rome, Italy. Dr Evangelidou is a Plastic Surgeon, Emirates Hospital Group Plastic and Reconstructive Surgery Department, Dubai, United Arab Emirates. Dr Ferrante is a Researcher, National Center of Disease Prevention and Health Promotion, Italian National Institute of Health, Rome, Italy.
Gianluigi
G
Ferrante
D000328:Adult; D001940:Breast / Q000601:surgery*; D019928:Breast Implantation / Q000009:adverse effects / Q000295:instrumentation*; D018427:Breast Implants / Q000009:adverse effects; D020099:Coated Materials, Biocompatible / Q000009:adverse effects; D005260:Female; D006406:Hematoma / Q000209:etiology; D006801:Humans; D057910:Implant Capsular Contracture / Q000209:etiology; D008499:Medical Records; D008875:Middle Aged; D011140:Polyurethanes / Q000009:adverse effects; D011474:Prosthesis Design; D012189:Retrospective Studies; D012307:Risk Factors; D020034:Silicone Gels / Q000009:adverse effects; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
D020099:Coated Materials, Biocompatible; D011140:Polyurethanes; D020034:Silicone Gels